In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chlordiazep-oxide HCl Drug Master File in Korea (Chlordiazep-oxide HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chlordiazep-oxide HCl. The MFDS reviews the Chlordiazep-oxide HCl KDMF as part of the drug registration process and uses the information provided in the Chlordiazep-oxide HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chlordiazep-oxide HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chlordiazep-oxide HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chlordiazep-oxide HCl suppliers with KDMF on PharmaCompass.